Chaloupka M, Westhofen T, Kretschmer A, Grimm T, Stief C, Apfelbeck M
Urologische Klinik und Poliklinik, Campus Großhadern, Klinikum der Universität München, Ludwig-Maximilians-Universität, Marchioninistraße 15, 81377, München, Deutschland.
Urologe A. 2019 Mar;58(3):329-340. doi: 10.1007/s00120-019-0894-5.
Prostate cancer is a heterogeneous disease. In cases of low-risk prostate cancer, active surveillance represents an attractive alternative treatment. Significant complications of a definitive treatment can therefore be delayed or completely avoided. Despite strict inclusion criteria for active surveillance, the diagnosis of low-risk prostate cancer can be inaccurate and there is therefore a risk of missing the optimal point in time for definitive treatment. Multimodal diagnostics and continuous aftercare are therefore crucial.
前列腺癌是一种异质性疾病。对于低风险前列腺癌病例，主动监测是一种有吸引力的替代治疗方法。因此，可以延迟或完全避免确定性治疗的重大并发症。尽管主动监测有严格的纳入标准，但低风险前列腺癌的诊断可能不准确，因此存在错过确定性治疗最佳时机的风险。因此，多模式诊断和持续的后续护理至关重要。
